Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.3.3.1 (
citrate synthase
)
4,488
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Aspergillus oryzae
is traditionally used in East Asia for the production of food and brewing. In addition, it has been developed into a suitable host for the heterologous expression of natural product biosynthetic genes and gene clusters, enabling the functional analysis of the encoded enzymes.
A. oryzae
shares a 99.5% genome homology with
Aspergillus flavus
, but their secondary metabolomes differ significantly and various compounds unique to
A. oryzae
have been reported. While using
A. oryzae
as a host for heterologous expression experiments we discovered two new metabolites in extracts of
A. oryzae
M-2-3 with an unusual maleidride backbone, which were named oryzine A and B. Their structures were elucidated by high resolution mass spectrometry (HRMS) and nuclear magnetic resonance (NMR) analysis. Their structural relationships with known maleidrides implied involvement of a
citrate synthase
(CS) and a polyketide (
PKS
) or fatty acid synthase (FAS) in their biosynthesis. Analysis of the
A. oryzae
genome revealed a single putative biosynthetic gene cluster (BGC) consistent with the hypothetical biosynthesis of the oryzines. These findings increase knowledge of the chemical potential of
A. oryzae
and are the first attempt to link a novel product of this fungus with genomic data.
...
PMID:Oryzines A & B, Maleidride Congeners from
Aspergillus oryzae
and Their Putative Biosynthesis. 3010 50